Viva Biotech Holdings (FRA:VB0)
0.2160
-0.0040 (-1.82%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Contract Development Manufacture Organisation and Commercialisation | 1.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Development Manufacture Organisation and Commercialisation Growth | -11.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Discovery | 859.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Discovery Growth | -7.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Viva BioInnovator | 19.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| United States | 862.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -3.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union | 675.83M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union Growth | 3.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 289.73M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -18.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Asian Countries | 209.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Asian Countries Growth | -34.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries/Regions | 66.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries/Regions Growth | -35.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa | 49.08M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa Growth | -1.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|